so Bansky thanks NHS staff in Southampton with original painting By www.bbc.co.uk Published On :: Wed, 06 May 2020 20:47:12 GMT The elusive artist's latest work, Game Changer, is on display at Southampton General Hospital. Full Article
so Tekashi69 Sounds Off In Live Stream, Sets Records With Epic Rant By www.tmz.com Published On :: 2020-05-08T20:22:14+00:00 Tekashi just streamed from in-home incarceration, setting an Instagram Live record with 2 million people tuning in. 6ix9ine trolled off the bat, bumping "Bad Boys" while toying with a pair of handcuffs. Tekashi got a lot off his plate ... admitting… Full Article
so UFC's Jacare Souza Tests Positive for COVID-19, Out of UFC 249 By www.tmz.com Published On :: 2020-05-09T02:57:10+00:00 UFC fighter Jacare Souza has tested positive for coronavirus and will NOT participate in his scheduled fight at UFC 249 on Saturday, the UFC confirms to TMZ Sports. The 40-year-old Brazilian was slated to fight Uriah Hall on the undercard of the… Full Article
so StreamLink Software Secures $2,600,000 New Funding Round By www.sandhill.com Published On :: Tue, 01 Nov 2016 07:00:06 +0000 StreamLink Software began as nonprofit executives saw a need for solutions to common management issues. When it became clear there was gap in quality, affordable products, StreamLink Software was formed to develop them. Full Article
so Solovis Receives $1,250,000 New Financing By www.sandhill.com Published On :: Tue, 01 Nov 2016 07:00:06 +0000 You’re not just getting great software. We’ve sat in your seat and wished there was a better way, so we built it. We provide a multi-asset class portfolio management and reporting system. Full Article
so The Voice contestants team up for NHS song after coronavirus stopped live shows By www.manchestereveningnews.co.uk Published On :: Sun, 3 May 2020 14:26:01 +0000 The show was postponed last month because of the COVID-19 pandemic Full Article Celebs
so Gemma Atkinson opens up about her new diet that proved people wrong By www.manchestereveningnews.co.uk Published On :: Mon, 4 May 2020 14:44:53 +0000 The Hits Radio host is feeling better than ever Full Article Celebs
so Jason Manford 'livid' after being knocked back by Tesco for a job By www.manchestereveningnews.co.uk Published On :: Tue, 5 May 2020 10:29:42 +0000 The Salford comic applied for a job at the Aldery Road Express store in Wilmslow Full Article Celebs
so Tesco issues lovely response to Jason Manford after he is rejected for job By www.manchestereveningnews.co.uk Published On :: Tue, 5 May 2020 13:20:04 +0000 Jason, from Salford, joked that he was 'livid' at the response but admitted he did genuinely apply for the supermarket job Full Article Celebs
so Iceland has given Jason Manford a very generous offer after Tesco knockback By www.manchestereveningnews.co.uk Published On :: Wed, 6 May 2020 09:04:20 +0000 Iceland has put in a job offer for the Salford comic after Tesco didn't hire him Full Article Celebs
so Adele's former personal trainer speaks about star's dramatic weight loss By www.manchestereveningnews.co.uk Published On :: Fri, 8 May 2020 13:41:47 +0000 The singer shared a post on Instagram to mark her 32nd birthday, revealing her slimmer frame Full Article Celebs
so Corrie star Colson Smith almost unrecognisable after incredible weight loss By www.manchestereveningnews.co.uk Published On :: Fri, 8 May 2020 17:59:25 +0000 The Corrie favourite has stunned fans with his new look after taking up running Full Article Celebs
so The Enterprise 2020 Report: Software CEO Briefing By sandhill.com Published On :: Wed, 11 Mar 2020 00:00:00 +0000 At the annual invite-only 2020 Enterprise Retreat in Half Moon Bay, CA, 100 enterprise leaders gathered in a social-media free environment, to network, discuss hot topics and dive into provocative, insightful off-the-record 'State of the Union' presentations. This report details their findings. Keep on reading: The Enterprise 2020 Report: Software CEO Briefing Full Article
so Finance ministry set to extend anti─dumping duty on import of sodium citrate from China By pharmabiz.com Published On :: 20200507080005 Full Article
so WBPC soon to open DIC at Council office to provide information on medication & safety measures to combat COVID─19 By pharmabiz.com Published On :: 20200508080003 Full Article
so Soft Actuator and Sensor for Underactive Bladder Treatment By feedproxy.google.com Published On :: Wed, 06 May 2020 16:07:55 +0000 Researchers at the National University of Singapore have developed a soft sensor and actuator to monitor bladder volume and help empty it on-demand. The device is intended to be implanted on the bladder surface during a surgical procedure to treat patients who cannot completely empty their bladders voluntarily. Patients can suffer from an underactive bladder […] Full Article Neurology Rehab Surgery Urology
so Stanford Bioengineers Innovate Multiple Solutions to Tackle COVID-19 By feedproxy.google.com Published On :: Wed, 06 May 2020 18:28:43 +0000 The current pandemic is revealing the level of commitment needed from multiple sectors to deliver innovative solutions to tackle severe shortages of personal protective equipment, ventilators, and raw materials. Researchers at the Prakash lab at Stanford University are no stranger to taking up extreme challenges, and they have kept up their reputation by coming up […] Full Article Critical Care Materials Public Health
so Aquadex Ultrafiltration for Critical COVID Patients: Interview with John Erb, CEO at CHF Solutions By feedproxy.google.com Published On :: Wed, 06 May 2020 19:14:03 +0000 As the COVID-19 pandemic continues, many healthcare facilities around the world are inundated with critically ill patients, and resources such as equipment and staff are stretched thin. Shortages of critical equipment, such as ventilators, can mean the difference between life and death for patients, and the need to keep critically ill patients comfortable and alive […] Full Article Critical Care Exclusive
so How Compounding Solutions are meeting the demand for medical materials during Covid-19 By www.medicalplasticsnews.com Published On :: Thu, 23 Apr 2020 12:22:57 -0000 Since early February, custom material solutions provider, Compounding Solutions, has been working hard to meet material demands related to Covid-19. Full Article
so The force: How to improve ultrasonic plastic welding By www.medicalplasticsnews.com Published On :: Fri, 24 Apr 2020 11:34:58 -0000 Tom Hoover, senior medical business development manager – Americas, assembly technologies, at global technology and manufacturing company, Emerson, explains how ultrasonic plastic welding is improved through improved force control. Full Article
so Ventilators from Dyson are 'no longer required' in UK By www.medicalplasticsnews.com Published On :: Mon, 27 Apr 2020 10:10:43 -0000 The Dyson CoVent ventilators are no longer required in the UK, according to a statement from Sir James Dyson. Full Article
so University of Glasgow issues plea for acetate sheets to help produce plastic visors By www.medicalplasticsnews.com Published On :: Mon, 04 May 2020 14:02:24 -0000 Engineers from the University of Glasgow are responding to the coronavirus pandemic by producing up to 1,000 pieces of Personal Protective Equipment (PPE) each day. Full Article
so FDA May Renege on Soy Heart Claim (Reuters</em>) By www.medpagetoday.com Published On :: Mon, 30 Oct 2017 16:16:17 -0400 Says the evidence is equivocal Full Article
so GSK hires computational drug design expert Dr Kim Branson as new head of machine learning and AI By www.pharmafile.com Published On :: Wed, 10 Jul 2019 11:24:21 +0000 British multinational GlaxoSmithKline have hired computational drug design expert Dr Kim Branson as the company’s new Senior Vice President, Global Head of Artificial Intelligence and Machine Learning. In his new role, the biotech veteran will oversee projects which use AI to identify novel targets for potential medicines. Dr Branson brings to the role more than 15 years’ worth of experience in biotech and academia having held positions at a number of Silicon Valley firms including Gliimpse, Lumia and Hessian Informatics. read more Full Article Research and Development Medical Communications Sales and Marketing Business Services Manufacturing and Production
so Dr John McHutchinson steps down from Gilead with $1.1 million goodbye By www.pharmafile.com Published On :: Thu, 18 Jul 2019 16:03:27 +0000 Gilead has said that Dr John McHutchison is stepping down after nine years at the firm. Gilead’s Chief Scientific Officer and Head of Research and Development has decided to leave the company next month, Gilead said. Under McHutchinson, Gilead developed five new hepatitis drugs, which have been used by as many as 3.2 million people around the world. read more Full Article Research and Development Medical Communications Sales and Marketing Business Services Manufacturing and Production
so ABPI Chief Executive Mike Thompson to retire by the end of 2019 By www.pharmafile.com Published On :: Wed, 24 Jul 2019 13:18:21 +0000 Chief Executive Mike Thompson is to retire from his role at the Association of the British Pharmaceutical Industry (ABPI) by the end of this year. His decision to leave the association marks the end of a three-year run beginning in March 2016, when stepped in to take up the mantle from Alison Clough, who had served as the acting Chief Executive for much of 2015. read more Full Article Research and Development Medical Communications Sales and Marketing Business Services Manufacturing and Production
so Troy Robinson promoted to managing director of Chugai Pharma Europe By www.pharmafile.com Published On :: Tue, 06 Aug 2019 16:14:25 +0000 Troy Robinson has been taken on as the new managing director of Chugai Pharma Europe. Mike Crosher will succeed him in his current role as managing director of Chugai Pharma UK. Chugai Pharma Europe (CPE) has promoted Troy Robinson and Mike Crosher into the positions of managing director of CPE and managing director of the firm’s UK subsidiary, Chugai Pharma UK (CPU). read more Full Article Research and Development Medical Communications Sales and Marketing Business Services Manufacturing and Production
so Gilead appoints Andrew Dickinson as CFO By www.pharmafile.com Published On :: Wed, 16 Oct 2019 11:46:13 +0000 Gilead Sciences have announced that Andrew Dickinson has been appointed as Chief Financial Officer (CFO) effective 1 November. Dickinson currently serves as the company’s Executive Vice President of Corporate Development and Strategy and in his new role will become part of a senior leadership team reporting directly to Chairman and Chief Executive Officer Daniel O’Day. read more Full Article Research and Development Medical Communications Sales and Marketing Business Services Manufacturing and Production
so Access to Drugs Before FDA Approval: Video Explainer with Christopher Robertson By blog.petrieflom.law.harvard.edu Published On :: Thu, 07 May 2020 14:55:20 +0000 In this video explainer, Christopher Robertson discusses the Right to Try Act and off-label use of pharmaceuticals with Alison Bateman-House. The post Access to Drugs Before FDA Approval: Video Explainer with Christopher Robertson appeared first on Bill of Health. Full Article Christopher Robertson FDA Health Law Policy Off-Label Use Pharmaceuticals Public Health alison bateman-house christopher robertson coronavirus coronavirus pandemic COVID-19 COVID19 off-label use Regulation right to try
so A $100 Million Biotech Deal Is Also A Tale Of Two Executives Facing Their Kids’ Deadly Diseases By www.forbes.com Published On :: Thu, 20 Sep 2018 10:00:00 +0000 “John, I’m very aware of your family’s journey, Twelve years ago I was one of the producers considering bidding on your life rights.” Full Article ticker=NASDAQ:FOLD ticker=NYSE:SNY byline=Matthew Herper
so EPS taps CluePoints for trial management solution By www.outsourcing-pharma.com Published On :: Mon, 27 Apr 2020 15:42:00 +0100 The Japanese pharma development firm will harness risk-based quality management solutions to help sponsors improve trial quality and safety. Full Article Clinical Development
so Research collaboration drives to accelerate COVID-19 solutions By www.outsourcing-pharma.com Published On :: Mon, 04 May 2020 13:56:00 +0100 Led by Medable, the multi-company effort is geared toward ramping up development of treatments, diagnostics and other solutions for the pandemic-causing virus. Full Article Clinical Development
so Insurers + PBMs + Specialty Pharmacies + Providers: Will Vertical Consolidation Disrupt Drug Channels in 2020? (rerun) By feeds.feedblitz.com Published On :: Mon, 04 May 2020 11:30:00 +0000 This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Industry Update and COVID-19 Impact: PBMs & Payers. Life was very different when I originally published today’s article. 2020 is not turning out to be quite what any of us expected. However, the pandemic has exposed some intriguing pros and cons of vertical consolidation. Click here to see the original post and comments from December 2019.The largest insurers, PBMs, and specialty pharmacies have now combined into vertically-integrated organizations. As I explain below, these companies have also been rapidly integrating with healthcare providers.I also provide an updated look at these companies and highlight strategies that they are using—or could use—to control the channel. I believe that these insurer / PBM / specialty pharmacy / provider organizations are poised to restructure U.S. drug channels by exerting greater control over patient access, sites of care/dispensing, and pricing.If they can effectively coordinate their sprawling business operations, they will pose a substantial threat of disruption to the existing commercial strategies of pharma companies. Will they succeed by better managing care and costs, or merely by extracting higher profits from our convoluted system?Read more » Full Article Accountable Care Organizations (ACOs) Buy-and-Bill Channel Management Mergers and Acquisitions PBMs Pharmacy Physicians Retail Clinics Specialty Drugs
so Express Scripts vs. CVS Health: Five Lessons From the 2020 Formulary Exclusions and Some Thoughts on Patient Impact (rerun) By feeds.feedblitz.com Published On :: Thu, 07 May 2020 11:30:00 +0000 This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Industry Update and COVID-19 Impact: PBMs & Payers. Today's rerun highlights one of the most effective tactics that PBMs have developed to extract deeper discounts from brand-name drug makers. COVID-19 seems likely shift the U.S. payer mix away from commercial health plans. Expect even tighter formulary management and more restrictions as PBMs work even harder to cut costs for their plan sponsor clients. Click here to see the original post and comments from January 2020.For 2020, the two largest pharmacy benefit managers (PBMs)—Express Scripts and the Caremark business of CVS Health—have again increased the number of drugs they have excluded from their standard formularies. The 2020 formulary exclusion lists are available below for your downloading pleasure.Below, I highlight my key takeaways from the 2020 lists:The number of exclusionsManagement of specialty drugsIndication-based formulariesThe slow adoption of biosimilarsThe PBMs’ patient-unfriendly exclusions in the hepatitis C categoryFormulary exclusions have emerged as a powerful tool for PBMs to gain additional negotiating leverage against manufacturers. The prospect of exclusion leads manufacturers to offer deeper rebates to avoid being cut from the formulary. Exclusions are therefore a key factor behind falling brand-name net drug prices.Read on for a look at this year’s exclusions along with some closing thoughts on what exclusions mean for patients.Read more » Full Article Benefit Design Biosimilars PBMs Specialty Drugs
so To Prevent the Next Pandemic, End Unequal Access to Natural Resources By blogs.scientificamerican.com Published On :: Thu, 07 May 2020 16:00:00 GMT Safeguarding public health requires rethinking our relationship to the environment and the inequities that drive its destruction -- Read more on ScientificAmerican.com Full Article Health Environment
so Soils Store Huge Amounts of Carbon, Warming May Unleash It By www.scientificamerican.com Published On :: Fri, 08 May 2020 16:30:00 GMT Higher temperatures and wetter weather may spur soil microbes to release more carbon into the atmosphere -- Read more on ScientificAmerican.com Full Article Sustainability Climate EARTH Environment
so World's stock markets soar on coronavirus treatment hopes By www.theguardian.com Published On :: 2020-04-29T17:17:35Z Investors shrug off US growth gloom after promising data from remdesivir drug trialCoronavirus – latest updatesSee all our coronavirus coverageShares have soared on the world’s stock markets after investors shrugged off a deep slump in the US economy and pinned their hopes on a possible breakthrough in treatment for Covid-19.Despite news that the longest expansion in US history came to an abrupt end in the first three months of 2020, financial markets were buoyed by an update from the American biopharma company Gilead Sciences on its experimental drug remdesivir. Continue reading... Full Article Stock markets US economic growth and recession Business Economics Pharmaceuticals industry Coronavirus outbreak Science Infectious diseases Medical research Microbiology Biology World news FTSE US news US economy Global economy
so Promising drug against Covid-19 unlikely to be available in UK soon By www.theguardian.com Published On :: 2020-04-30T16:50:55Z Trial of remdesivir shows fewer deaths and shorter hospital staysCoronavirus – latest updatesSee all our coronavirus coverageThe first drug against Covid-19 to show promise in trials, reducing the time seriously ill people take to recover in hospital, is unlikely to be available widely in the UK soon, it has emerged.Forty-six people in the UK have received remdesivir as part of the European arm of an international trial. Researchers would like to have given the drug to more patients but did not have the supplies. Related: Coronavirus: what do scientists know about Covid-19 so far? Continue reading... Full Article Medical research Health Pharmaceuticals industry Coronavirus outbreak Science UK news Society
so South Korean researchers start testing pancreatitis drug in COVID-19 patients By www.pharmafile.com Published On :: Tue, 28 Apr 2020 10:19:05 +0000 The South Korean Ministry of Food and Drug Safety have approved a local trial to evaluate nafamostat’s effectiveness in COVID-19 patients. Full Article coronavirus COVID-19 Pancreas Pancreatitis Manufacturing and Production
so South Korea says Ebola drug remdesivir may not be suitable for all coronavirus patients By www.pharmafile.com Published On :: Wed, 06 May 2020 11:29:32 +0000 South Korea says that remdesivir, traditionally used in treating Ebola, may not be effective enough in treating COVID-19 patients. Full Article coronavirus COVID-19 Research and Development south korea
so Rick Simpson Oil (RSO): Benefits, Effects and Research By www.thestreet.com Published On :: Tue, 18 Feb 2020 10:42:15 EST Click to view a price quote on TLRY. Full Article
so Loss of smell associated with milder clinical course in COVID-19 By www.pharmanews.eu Published On :: Tue, 28 Apr 2020 10:00:00 +0200 Following an earlier study that validated the loss of smell and taste as indicators of SARS-CoV-2 infection, researchers at UC San Diego Health report in newly published findings that olfactory impairment suggests the resulting COVID-19 disease is more likely to be mild to moderate, a potential early indicator that could help health care providers determine which patients may require hospitalization. Full Article Featured Research Research & Development
so Akebia soars on positive Ph III trial results for vadadustat By www.thepharmaletter.com Published On :: Tue, 05 May 2020 19:20:00 +0100 Shares of US biotech Akebia Therapeutics were up more than 35% at $11.72 by early afternoon today, after… Full Article Akebia Therapeutics/Biotechnology/Drug Trial/Nephrology and Hepatology/Research/USA/vadadustat
so Otezla’s impact shown in milder psoriasis By www.thepharmaletter.com Published On :: Wed, 06 May 2020 16:46:00 +0100 Amgen’s Otezla (apremilast), a drug divested by Celgene ahead of its acquisition by Bristol-Myers Squibb,… Full Article Amgen/Biotechnology/Dermatologicals/Drug Trial/Inflammatory diseases/Otezla/Research/USA
so Teva soars as 1st-qtr beats expectations By www.thepharmaletter.com Published On :: Thu, 07 May 2020 17:21:00 +0100 Israel-based Teva Pharmaceutical Industries today reported results for the quarter ended March 31, 2020,… Full Article Ajovy/Analgesia/Austedo/Copaxone/Financial/Generics/Israel/Musculoskeletal/Rare diseases/Teva Pharmaceutical Industries/Treanda
so jCyte out-licenses rare vision disorder treatment for $252 million By www.thepharmaletter.com Published On :: Sat, 09 May 2020 14:46:00 +0100 US biotech firm jCyte Inc has entered into a licensing agreement with Japanese ophthalmology specialist… Full Article Biotechnology/Deals/Japan/jCell/jCyte Inc/Licensing/Ophthalmics/Rare diseases/Santen/USA/Vision disorder
so With the world waiting, Roche socks $459M into COVID-19 antibody test production By www.fiercepharma.com Published On :: Mon, 04 May 2020 15:05:01 +0000 Roche scored a major win with the FDA's backing for its COVID-19 antibody tests last week in a field marked by products of questionable quality. Now, to cover its booming production goals, Roche plans to infuse nearly half-a-billion dollars into its German manufacturing facility. Full Article
so Amgen ramps up Otezla expansion effort with positive data in mild psoriasis By www.fiercepharma.com Published On :: Wed, 06 May 2020 18:22:16 +0000 Amgen is planning to file for FDA approval of Otezla in mild to moderate plaque psoriasis based on new data showing patients on the drug experienced significant improvements in their symptoms. The label expansion will be key to Amgen's ability to recoup the $13.4 billion it paid to acquire the drug from Celgene last year. Full Article
so Bristol Myers Squibb's blood thinner Eliquis soars on COVID-19 demand, but Opdivo could suffer: execs By www.fiercepharma.com Published On :: Thu, 07 May 2020 14:53:18 +0000 Bristol Myers Squibb CEO Giovanni Caforio credited COVID-19-related stocking for high sales of some products in the first quarter, including Eliquis, a blood thinner that's being snapped up to reduce clotting risk in patients with the virus. But the pandemic has limited access to oncology clinics and other non-COVID-19 services, raising challenges that could impact sales later this year. Full Article
so Federal agency finds 'reasonable grounds to believe' Rick Bright's whistleblower claims: NYT By www.fiercepharma.com Published On :: Fri, 08 May 2020 19:45:56 +0000 Only days after former BARDA chief Rick Bright filed a whistleblower complaint alleging retaliation by the Trump administration, the U.S. Office of the Special Counsel has recommended his temporary reinstatement, the New York Times reports. Full Article